Comparison of two omalizumab dose-reduction strategies in patients with chronic spontaneous urticaria during the control phase: standard dose maintenance therapy versus extended interval dose reduction. [PDF]
Am J Transl ResZhang L, Chen J.
europepmc +1 more source
Good outcomes of pregnancy in two cases of women treated with omalizumab due to the severe asthma [PDF]
, 2013 Izabela Kuprys-Lipinska, Piotr Kuna
core +1 more source
Quantitative CT assessment of structural and functional response to omalizumab in severe allergic asthma: a prospective real-world study. [PDF]
BMC Pulm MedLiu S, Li Y, Wu J, Ye Z, Zhang Y, Ma H.
europepmc +1 more source
Immunological Basis of Chronic Spontaneous Urticaria: Immunoglobulin E and Beyond. [PDF]
Yonsei Med JRhyou HI, Nam YH, Park JW, Park HS.
europepmc +1 more source
Case Report: Hereditary Angioedema Accompanied by Chronic Spontaneous Urticaria. [PDF]
Clin Cosmet Investig DermatolWang H, Shen Y.
europepmc +1 more source
Heterogeneity in clinical appearance of chronic spontaneous urticaria: A cross-sectional analysis of a retrospective cohort. [PDF]
World Allergy Organ JToprak İD +9 more
europepmc +1 more source
Differential MicroRNA Expression in Chronic Spontaneous Urticaria in Relation to Treatment Response. [PDF]
Allergy Asthma Immunol ResLee Y +6 more
europepmc +1 more source
Treatments and Targets to Achieve Disease Control in Chronic Spontaneous Urticaria: Current and Emerging Therapeutic Options. [PDF]
J Inflamm ResØstergaard CES, Thomsen SF, Zhang DG.
europepmc +1 more source
Fab-Fc and Fab-Fab interactions of variable strength and valency contribute to the high concentration viscosity of IgG<sub>1</sub> antibodies. [PDF]
Proc Natl Acad Sci U S AHeisler J +5 more
europepmc +1 more source
A successful treatment of urticaria pigmentosa with omalizumab in a pediatric patient: a case report. [PDF]
AME Case RepAlhajri A +6 more
europepmc +1 more source